Cogent Biosciences COGT
NASDAQ COGT
$30.90 -0.69 (-2.18%)
As of: Oct 2, 2026 · 3:12 PM EDT

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Cogent Biosciences' Depreciation & Amortization (CF) was $741,000 in Q2 2026, up 13.1% from $655,000 a year earlier and up 18.4% from the prior quarter.

Analysis

Cogent Biosciences (COGT) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cogent Biosciences' Depreciation & Amortization (CF) was $2.67 million through Jun 30, 2026, up 3.2% year-over-year; for FY2025, it was $2.6 million, up 4.0% from FY2024.

  • Depreciation & Amortization (CF) has now increased for four consecutive years, with a five-year compound annual growth rate of 29.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $2.5 million in FY2024 (+8.7%), $2.3 million in FY2023 (+187.5%), $800,000 in FY2022 (+444.2%) and $147,000 in FY2021 (-79.6%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2017.
  • Compared with a year earlier, Depreciation & Amortization (CF) was higher in six of the last eight quarters, with growth averaging 5.2%.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2023 (growth of 666.7%); the worst was Q3 2021 (a decline of 60.7%).
  • Per Business Quant data, COGT's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $626,000 (Q1 2026), $664,000 (Q4 2025) and $641,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Cogent Biosciences 5.49 Bn 5.49 Bn - 741,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 741,000.00
Mar 31, 2026 626,000.00
Dec 31, 2025 664,000.00
Sep 30, 2025 641,000.00
Jun 30, 2025 655,000.00
Mar 31, 2025 640,000.00
Dec 31, 2024 675,000.00
Sep 30, 2024 620,000.00
Jun 30, 2024 606,000.00
Mar 31, 2024 599,000.00
Dec 31, 2023 628,000.00
Sep 30, 2023 581,000.00
Jun 30, 2023 562,000.00
Mar 31, 2023 529,000.00
Dec 31, 2022 378,000.00
Sep 30, 2022 256,000.00
Jun 30, 2022 97,000.00
Mar 31, 2022 69,000.00
Dec 31, 2021 68,000.00
Sep 30, 2021 48,000.00
API Access

Cogent Biosciences Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=COGT&period=max&api_key=YOUR_API_KEY